RMD
$225.98+2.40%
as of close, Oct 7, 2026
☾ AH $225.98 +2.40%
RMD — ResMed Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDDEDEDEDED
60.080.0100.0120.0140.0160.0180.0200.0220.0240.0260.0280.0020.0M$225.98—20162019202120242026
2026-10-07
Price$225.98
MA20$211.91
MA50$238.73
Vol4.0M
Key stats#
Price data
- Price
- $225.98
- YTD price return
- -6.18%
- YTD total return
- -5.41%
- Next earnings
- Oct 29, 2026 · After close
- Market cap
- 32.6B
- Enterprise value
- 32B
- Shares outstanding
- 144.3M
- 52W low
- $180.27
- 52W high
- $284.87
- From 52W high
- -20.67%
- From 52W low
- +25.36%
- 52W range
- 44%
- Beta
- 0.75
Volume
- Rel volume
- 0.90×
- 30D volume
- 1.2M
- 30D $ vol
- 282.9M
Insider trading
- Insider net 1W
- none
- Insider net 1M
- none
- Insider net 3M
- −$4.2M
- Insider net 1Y
- −$15.2M
Form 4 transactions by trade date, as filed; latest on file 2026-09-08.
Fundamentals
- Sales (ttm)
- 5.7B
- Sales/share
- $39.19
- EPS (ttm)
- $10.43
- FCF (ttm)
- 1.6B
- FCF/share
- $11.44
- Book value/share
- $45.65
- Net margin
- 26.94%
- ROE
- 23.13%
- ROA
- 16.99%
- Debt / equity
- 0.06×
- Current ratio
- 3.10
Growth (CAGR, ttm) · 10Y
- Sales
- +9.86%+10.21%+12.08%+11.89%
- Net income
- +8.76%+19.28%+26.28%+15.77%
- FCF
- -0.73%+42.19%+21.08%+12.92%
- Shares
- -1.48%-0.64%-0.20%+0.25%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +9.68%+19.64%+26.35%+15.40%
- Sales/share
- +11.51%+10.92%+12.30%+11.61%
- FCF/share
- +0.76%+43.11%+21.32%+12.64%
- Book value/share
- +12.01%+17.58%+18.18%+14.25%
- Dividend/share
- +13.22%+10.89%+9.00%+7.18%
- Price
- -20.24%+15.50%-2.39%+13.36%
- Total return
- -19.40%+16.64%-1.50%+14.62%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 21.7×
- P/OI (ttm)
- 17.3×
- Fwd P/E
- 16.5×
- P/S (ttm)
- 5.8×
- P/B (mrq)
- 5.0×
- P/FCF (ttm)
- 19.8×
- EV/EBITDA (fy)
- 15.3×
- EV/Sales (ttm)
- 5.7×
- FCF yield (ttm)
- 5.06%
- Dividend yield (fwd)
- 1.17%
- Dividend yield (ttm)
- 1.09%
- Dividend/share (fwd)
- $2.64
- Buyback yield (realized, 1y)
- 1.48%
- Shareholder yield (realized, 1y)
- 2.40%
- Buyback yield (cash, ttm)
- 1.92%
- Shareholder yield (cash, ttm)
- 2.99%
Vs own 10Y history
- P/E
- 4th
- P/OI
- 4th
- P/S
- 19th
- P/B
- 6th
- P/FCF
- 7th
Bar = where today’s multiple sits in RMD’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-07#
1D
+2.40%
5D
+2.21%
1M
-1.04%
3M
+2.84%
YTD
-6.18%
1Y
-20.23%
5Y
-11.38%
Recent filings#
All filings and insider trades →Financial statements
Open full RMD financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +3.42% | +2.70% |
| JNJ | Johnson & Johnson | -6.10% | +1.44% |
| ABBV | AbbVie Inc. | +5.81% | +1.75% |
| MRK | Merck & Co. Inc. | -5.02% | +0.60% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -5.33% | -0.09% |
| TMO | Thermo Fisher Scientific Inc. | +7.87% | +0.83% |
| AMGN | Amgen Inc. | -5.52% | +2.60% |
| GILD | Gilead Sciences Inc. | -2.75% | +1.82% |
